Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology. 2003;62(5):28–37. https://doi.org/10.1016/j.urology.2003.09.050.

Article  PubMed  Google Scholar 

Bo K, Frawley HC, Haylen BT, et al. An international urogynecological association (IUGA)/International continence society (ICS) joint report on the terminology for the Conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213. https://doi.org/10.1007/s00192-016-3123-4.

Article  PubMed  Google Scholar 

Raju R, Linder BJ. Evaluation and Treatment of Overactive Bladder in Women. Mayo Clinic Proceedings. 2020;95(2):370–377. https://doi.org/10.1016/j.mayocp.2019.11.024

White N, Iglesia CB. Overactive bladder. Obstet Gynecol Clin N Am. 2016;43(1):59–68. https://doi.org/10.1016/j.ogc.2015.10.002.

Article  Google Scholar 

Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the united States stratified by sex and age. Urology. 2011;77(5):1081–7. https://doi.org/10.1016/j.urology.2010.08.039.

Article  PubMed  Google Scholar 

Coyne KS, Sexton CC, Bell JA, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by Racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230–7. https://doi.org/10.1002/nau.22295.

Article  PubMed  Google Scholar 

Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the united States. World J Urol. 2003;20(6):327–36. https://doi.org/10.1007/s00345-002-0301-4.

Article  CAS  PubMed  Google Scholar 

Coyne KS, Margolis MK, Kopp ZS, Kaplan SA. Racial differences in the prevalence of overactive bladder in the united States from the epidemiology of LUTS (EpiLUTS) study. Urology. 2012;79(1):95–101. https://doi.org/10.1016/j.urology.2011.09.010.

Article  PubMed  Google Scholar 

Eleenemchukwu E, Cameron A. Management of complex OAB patients: A call to action. Neurourol Urodyn. 2022;41(8):1938–9. https://doi.org/10.1002/nau.25048.

Article  Google Scholar 

Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (Non-Neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558–63. https://doi.org/10.1097/JU.0000000000000309.

Article  PubMed  Google Scholar 

Rovner E, Chai TC, Jacobs S, et al. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020;39(2):744–53. https://doi.org/10.1002/nau.24272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device| ClinicalTrials.gov. Accessed September 19. 2024. https://clinicaltrials.gov/study/NCT04001426

Usability Study of the FemPulse System| ClinicalTrials.gov. Accessed September 19. 2024. https://clinicaltrials.gov/study/NCT06347380?term=fempulse&rank=1

Brown J, McGhan W, Chokroverty S. Comorbidities associated with overactive bladder. Am J Manag Care. 2000;6:S574–9.

CAS  PubMed  Google Scholar 

Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive bladder: A systematic review. J Health Psychol. 2016;21(1):69–81. https://doi.org/10.1177/1359105314522084.

Article  PubMed  Google Scholar 

Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int. 2011;108(9):1459–71. https://doi.org/10.1111/j.1464-410X.2010.10013.x.

Article  PubMed  Google Scholar 

Coyne KS, Wein AJ, Tubaro A, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103(Suppl 3):4–11. https://doi.org/10.1111/j.1464-410X.2009.08371.x.

Article  PubMed  Google Scholar 

Coyne KS, Sexton CC, Thompson CL, et al. Impact of overactive bladder on work productivity. Urology. 2012;80(1):97–103. https://doi.org/10.1016/j.urology.2012.03.039.

Article  PubMed  Google Scholar 

Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep. 2016;11(1):8–13. https://doi.org/10.1007/s11884-016-0344-9.

Article  PubMed  PubMed Central  Google Scholar 

Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int. 2006;97(1):96–100. https://doi.org/10.1111/j.1464-410X.2005.05889.x.

Article  PubMed  Google Scholar 

Davenport A, Stark S, Quian A, Sheyn D, Mangel J. A Patient-Centered approach to refractory overactive bladder and barriers to Third-Line therapy. Obstet Gynecol. 2019;134(1):141–8. https://doi.org/10.1097/AOG.0000000000003320.

Article  PubMed  Google Scholar 

Smith AL, Nissim HA, Le TX, et al. Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology. 2011;77(1):55–9. https://doi.org/10.1016/j.urology.2010.07.460.

Article  PubMed  Google Scholar 

Melville JL, Wagner LE, Fan MY, Katon WJ, Newton KM. Women’s perceptions about the etiology of urinary incontinence. J Womens Health (Larchmt). 2008;17(7):1093–8. https://doi.org/10.1089/jwh.2007.0606.

Article  PubMed  PubMed Central  Google Scholar 

Milne J. The impact of information on health behaviors of older adults with urinary incontinence. Clin Nurs Res. 2000;9(2):161–76. https://doi.org/10.1177/105477380000900205.

Article  CAS  PubMed  Google Scholar 

Anger JT, Lee UJ, Mittal BM, et al. Health literacy and disease Understanding among aging women with pelvic floor disorders. Female Pelvic Med Reconstr Surg. 2012;18(6):340–3. https://doi.org/10.1097/SPV.0b013e31826fb8d3.

Article  PubMed  PubMed Central  Google Scholar 

Irwin DE, Milsom I, Kopp Z, Abrams P, EPIC Study Group. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol. 2008;53(5):1029–37. https://doi.org/10.1016/j.eururo.2008.01.027.

Article  PubMed  Google Scholar 

Shaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with urinary symptoms. Fam Pract. 2001;18(1):48–52. https://doi.org/10.1093/fampra/18.1.48.

Article  CAS  PubMed  Google Scholar 

Benner JS, Becker R, Fanning K, et al. Bother related to bladder control and health care seeking behavior in adults in the united States. J Urol. 2009;181(6):2591–8. https://doi.org/10.1016/j.juro.2009.02.018.

Article  PubMed  Google Scholar 

Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the united States: results from EpiLUTS. Urology. 2012;80(1):90–6. https://doi.org/10.1016/j.urology.2012.04.004.

Article  PubMed  Google Scholar 

Yeowell G, Smith P, Nazir J, Hakimi Z, Siddiqui E, Fatoye F. Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review. BMJ Open. 2018;8(11):e021889. https://doi.org/10.1136/bmjopen-2018-021889.

Article  PubMed  PubMed Central  Google Scholar 

Eleenemchukwu EA, Subak LL, Markland A. Barriers and facilitators to overactive bladder therapy adherence. Neurourol Urodyn. 2022;41(8):1983–92. https://doi.org/10.1002/nau.24936.

Article  CAS  Google Scholar 

Wagg A, Franks B, Ramos B, Berner T. Persistence and adherence with the new beta-3 receptor agonist, Mirabegron, versus antimuscarinics in overactive bladder: early experience in Canada. Can Urol Assoc J. 2015;9(9–10):343–50. https://doi.org/10.5489/cuaj.3098.

Article  PubMed  PubMed Central  Google Scholar 

Dorsthorst MJ, Heesakkers JPFA, van Balken MR. Long-term real‐life adherence of percutaneous tibial nerve stimulation in over 400 patients. Neurourol Urodyn. 2020;39(2):702–6. https://doi.org/10.1002/nau.24254.